Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists

被引:80
作者
Hillaert, S [1 ]
Van den Bossche, W [1 ]
机构
[1] State Univ Ghent, Fac Pharmaceut Sci, Dept Pharmaceut Anal, Lab Pharmaceut Chem & Drug Anal, B-9000 Ghent, Belgium
关键词
validation; pharmaceutical analysis; experimental design; angiotensin II receptor antagonists;
D O I
10.1016/S0021-9673(02)01247-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We optimized a capillary zone electrophoretic method for separation of six angiotensin-II-receptor antagonists (ARA-IIs): candesartan, eprosartan, irbesartan, losartan potassium, telmisartan, and valsartan. A three-level, full-factorial design was applied to study the effect of the pH and molarity of the running buffer on separation. Combination of the studied parameters permitted the separation of the six ARA-IIs, which was best carried out using 60 mM sodium phosphate buffer (pH 2.5). The same system can also be applied for the quantitative determination of these compounds, but only for the more soluble ones. Some parameters (linearity, precision and accuracy) were validated. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:323 / 333
页数:11
相关论文
共 26 条
[1]   High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436 BMS-186295) in human plasma and urine [J].
Chang, SY ;
Whigan, DB ;
Vachharajani, NN ;
Patel, R .
JOURNAL OF CHROMATOGRAPHY B, 1997, 702 (1-2) :149-155
[2]  
CHEN YC, 2001, YAOWU FENXI ZAZHI, V21, P196
[3]   Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate [J].
Farthing, D ;
Sica, D ;
Fakhry, I ;
Pedro, A ;
Gehr, TWB .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :374-378
[4]   Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester [J].
Francotte, E ;
Davatz, A ;
Richert, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 686 (01) :77-83
[5]   SIMULTANEOUS DETERMINATION OF A NOVEL ANGIOTENSIN-II RECEPTOR BLOCKING-AGENT, LOSARTAN, AND ITS METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FURTEK, CI ;
LO, MW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :295-301
[6]   A high-performance liquid chromatographic method for screening angiotensin II receptor antagonists in human urine [J].
González, L ;
Alonso, RM ;
Jiménez, RM .
CHROMATOGRAPHIA, 2000, 52 (11-12) :735-740
[7]   Optimisation of alachlor solid-phase microextraction from water samples using experimental design [J].
González-Barreiro, C ;
Lores, M ;
Casais, MC ;
Cela, R .
JOURNAL OF CHROMATOGRAPHY A, 2000, 896 (1-2) :373-379
[8]   Reversed-phase ion-pair liquid chromatography of a pharmaceutical compound and its photolytically transformed isomer [J].
Hsu, LC .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1998, 21 (11) :1685-1700
[9]   Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry [J].
Iwasa, T ;
Takano, T ;
Hara, K ;
Kamai, T .
JOURNAL OF CHROMATOGRAPHY B, 1999, 734 (02) :325-330
[10]  
JOHNSTON IC, 1997, J HYPERTENS S, V15, pS3